{"id":"W4245038343","doi":"10.1200/jco.2009.27.15_suppl.5041","title":"Prognostic factors for overall survival (OS) in patients with metastatic renal cell carcinoma (RCC) treated with vascular endothelial growth factor (VEGF)-targeted agents: Results from a large multicenter study","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Sunitinib; Internal medicine; Bevacizumab; Sorafenib; Proportional hazards model; Oncology; Progression-free survival; Population; Clinical endpoint; Gastroenterology; Vascular endothelial growth factor; Hazard ratio; Surgery; Confidence interval; Hepatocellular carcinoma; Overall survival; Clinical trial; Chemotherapy; VEGF receptors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001152579,0.0002925983,0.0003831354,0.0003691755,0.0003696934,0.0004319577,0.0003380115,0.000291586,0.000542071],"category_scores_gemma":[0.001729279,0.0001489861,0.0004442897,0.0007310208,0.0002718696,0.0002527175,0.0002802297,0.000357605,0.0001222447],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008235541,"about_ca_system_score_gemma":0.000882239,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0109409,"about_ca_topic_score_gemma":0.01413598,"domain_scores_codex":[0.9996315,0.0001049134,0.00002655725,0.00008480622,0.00009589095,0.00005628361],"domain_scores_gemma":[0.998869,0.0002528685,0.0004065486,0.0000717095,0.0001470157,0.0002527874],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007860144,0.00005268502,0.9968748,0.000008045892,0.0001209501,0.00003253864,0.00003656227,0.00006987657,0.0002540666,0.00000506316,0.0001262921,0.001632983],"study_design_scores_gemma":[0.00006999361,0.0002271745,0.9990302,0.000003098482,0.00007712105,0.0001241131,0.00003473779,0.0001921394,0.00006811111,0.000008778617,0.0001614069,0.00000311349],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994235,0.0002185289,0.00004141153,0.00002447119,0.000002093007,0.0000070334,0.0002045102,0.000001967398,0.00007643802],"genre_scores_gemma":[0.9992404,0.00007851126,0.00005965234,0.00001655285,0.000009891854,0.000008242584,0.0005484813,0.000001079834,0.0000373393],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0109409,"threshold_uncertainty_score":0.02175444,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07290138496579174,"score_gpt":0.3559160573981137,"score_spread":0.283014672432322,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}